Sidley is pleased to present its annual review addressing developments in securities class actions brought against life sciences companies in 2023.
In this publication, we begin with an overview and analysis of trends in federal district court and appellate decisions in these cases. We then provide summaries of the 31 decisions surveyed. Finally, we catalog the new securities class action complaints filed against life sciences companies in 2023.
Click here to download the PDF.
Click here to view a two-page summary.
Click here to order hard copies. Limited supply available.
